P
Peter Wipf
Researcher at University of Pittsburgh
Publications - 795
Citations - 27717
Peter Wipf is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Total synthesis & Transmetalation. The author has an hindex of 83, co-authored 767 publications receiving 25316 citations. Previous affiliations of Peter Wipf include University of California, Los Angeles & University of Vermont.
Papers
More filters
Journal ArticleDOI
A New Thiazole Synthesis by Cyclocondensation of Thioamides and Alkynyl(Aryl)Iodonium Reagents
Peter Wipf,Srikanth Venkatraman +1 more
Journal ArticleDOI
General Solution to the Synthesis of N-2-Substituted 1,2,3-Triazoles
TL;DR: The regioselective N-alkylation of 1,2,3-triazoles 1-6 was studied, providing a general, protective, group-free method for the synthesis of N-2-substituted triazoles.
Journal ArticleDOI
Total synthesis and revision of stereochemistry of the marine metabolite trunkamide A.
Peter Wipf,Yoshikazu Uto +1 more
TL;DR: This work reports the first preparation of actual trunkamide A in a total synthesis that serves as an unambiguous structural and stereochemical proof of this marine natural product's structure.
Journal ArticleDOI
Structure-activity and high-content imaging analyses of novel tubulysins.
Zhiyong Wang,Peter A. McPherson,Brianne S. Raccor,Raghavan Balachandran,Guangyu Zhu,Billy W. Day,Andreas Vogt,Peter Wipf +7 more
TL;DR: The synthesis and biological evaluation of three tubulysin analogs provides the first structure–activity relationship in this family of potent cytotoxic myxobacteria metabolites and encourages further development of these compounds as potential therapeutic agents in cancer treatment.
Journal ArticleDOI
Pyrimidinone-peptoid hybrid molecules with distinct effects on molecular chaperone function and cell proliferation.
Christine M. Wright,Raj J. Chovatiya,Nora E. Jameson,David M. Turner,Guangyu Zhu,Stefan Werner,Donna M. Huryn,James M. Pipas,Billy W. Day,Peter Wipf,Jeffrey L. Brodsky +10 more
TL;DR: Pyrimidinone-peptoid hybrid molecules are identified that inhibit cell proliferation with greater potency than previously described Hsp70 modulators and correlated with inhibition of J domain stimulation of HSp70.